Molecular Pharmacology Stock Market Value
| MLPH Stock | USD 0.0004 0.00 0.00% |
| Symbol | Molecular |
Molecular Pharmacology 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Molecular Pharmacology's pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Molecular Pharmacology.
| 10/04/2025 |
| 01/02/2026 |
If you would invest 0.00 in Molecular Pharmacology on October 4, 2025 and sell it all today you would earn a total of 0.00 from holding Molecular Pharmacology or generate 0.0% return on investment in Molecular Pharmacology over 90 days. Molecular Pharmacology Limited, a development stage company, develops and commercializes pain and inflammation managemen... More
Molecular Pharmacology Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Molecular Pharmacology's pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Molecular Pharmacology upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.1247 | |||
| Maximum Drawdown | 193.33 |
Molecular Pharmacology Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Molecular Pharmacology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Molecular Pharmacology's standard deviation. In reality, there are many statistical measures that can use Molecular Pharmacology historical prices to predict the future Molecular Pharmacology's volatility.| Risk Adjusted Performance | 0.0997 | |||
| Jensen Alpha | 2.58 | |||
| Total Risk Alpha | 1.15 | |||
| Treynor Ratio | (1.71) |
Molecular Pharmacology Backtested Returns
Molecular Pharmacology is out of control given 3 months investment horizon. Molecular Pharmacology has Sharpe Ratio of 0.13, which conveys that the firm had a 0.13 % return per unit of risk over the last 3 months. We were able to interpolate data for sixteen different technical indicators, which can help you to evaluate if expected returns of 2.64% are justified by taking the suggested risk. Use Molecular Pharmacology Mean Deviation of 6.63, risk adjusted performance of 0.0997, and Standard Deviation of 19.73 to evaluate company specific risk that cannot be diversified away. Molecular Pharmacology holds a performance score of 10 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -1.47, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Molecular Pharmacology are expected to decrease by larger amounts. On the other hand, during market turmoil, Molecular Pharmacology is expected to outperform it. Use Molecular Pharmacology variance and kurtosis , to analyze future returns on Molecular Pharmacology.
Auto-correlation | 0.00 |
No correlation between past and present
Molecular Pharmacology has no correlation between past and present. Overlapping area represents the amount of predictability between Molecular Pharmacology time series from 4th of October 2025 to 18th of November 2025 and 18th of November 2025 to 2nd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Molecular Pharmacology price movement. The serial correlation of 0.0 indicates that just 0.0% of current Molecular Pharmacology price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.94 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Molecular Pharmacology lagged returns against current returns
Autocorrelation, which is Molecular Pharmacology pink sheet's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Molecular Pharmacology's pink sheet expected returns. We can calculate the autocorrelation of Molecular Pharmacology returns to help us make a trade decision. For example, suppose you find that Molecular Pharmacology has exhibited high autocorrelation historically, and you observe that the pink sheet is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Molecular Pharmacology regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Molecular Pharmacology pink sheet is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Molecular Pharmacology pink sheet is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Molecular Pharmacology pink sheet over time.
Current vs Lagged Prices |
| Timeline |
Molecular Pharmacology Lagged Returns
When evaluating Molecular Pharmacology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Molecular Pharmacology pink sheet have on its future price. Molecular Pharmacology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Molecular Pharmacology autocorrelation shows the relationship between Molecular Pharmacology pink sheet current value and its past values and can show if there is a momentum factor associated with investing in Molecular Pharmacology.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in Molecular Pink Sheet
Molecular Pharmacology financial ratios help investors to determine whether Molecular Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Molecular with respect to the benefits of owning Molecular Pharmacology security.